{"id":"https://openalex.org/W1971362991","doi":"https://doi.org/10.1097/fjc.0b013e318033dfd4","title":"Eplerenone Attenuates Myocardial Fibrosis in the Angiotensin II-Induced Hypertensive Mouse: Involvement of Tenascin-C Induced by Aldosterone-Mediated Inflammation","display_name":"Eplerenone Attenuates Myocardial Fibrosis in the Angiotensin II-Induced Hypertensive Mouse: Involvement of Tenascin-C Induced by Aldosterone-Mediated Inflammation","publication_year":2007,"publication_date":"2007-05-01","ids":{"openalex":"https://openalex.org/W1971362991","doi":"https://doi.org/10.1097/fjc.0b013e318033dfd4","mag":"1971362991","pmid":"https://pubmed.ncbi.nlm.nih.gov/17513943"},"language":"en","primary_location":{"id":"doi:10.1097/fjc.0b013e318033dfd4","doi":"https://doi.org/10.1097/fjc.0b013e318033dfd4","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0b013e318033dfd4","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040297237","display_name":"Tomohiro Nishioka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178574317","display_name":"Mie University","ror":"https://ror.org/01529vy56","country_code":"JP","type":"education","lineage":["https://openalex.org/I178574317"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tomohiro Nishioka","raw_affiliation_strings":["Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine, Tsu, Japan","Department of Pathology and Matrix Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine, Tsu, Japan","institution_ids":["https://openalex.org/I178574317"]},{"raw_affiliation_string":"Department of Pathology and Matrix Biology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102884477","display_name":"M. Suzuki","orcid":"https://orcid.org/0000-0002-1732-0663","observed_orcids":["https://orcid.org/0000-0002-1732-0663"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Maiko Suzuki","raw_affiliation_strings":["Department of Pathology and Matrix Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Matrix Biology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110072341","display_name":"Katsuya Onishi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178574317","display_name":"Mie University","ror":"https://ror.org/01529vy56","country_code":"JP","type":"education","lineage":["https://openalex.org/I178574317"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsuya Onishi","raw_affiliation_strings":["Department of Laboratory Medicine, Mie University Graduate School of Medicine, Tsu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Mie University Graduate School of Medicine, Tsu","institution_ids":["https://openalex.org/I178574317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068623243","display_name":"Nobuyuki Takakura","orcid":"https://orcid.org/0000-0003-0397-8605","observed_orcids":["https://orcid.org/0000-0003-0397-8605"]},"institutions":[{"id":"https://openalex.org/I4405287703","display_name":"Research Institute for Microbial Diseases, The University of Osaka","ror":"https://ror.org/05y8y8a85","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405287703","https://openalex.org/I98285908"]},{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuyuki Takakura","raw_affiliation_strings":["Department for Signal Transduction Research Institute for Microbial Diseases, Osaka University, Suita"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Signal Transduction Research Institute for Microbial Diseases, Osaka University, Suita","institution_ids":["https://openalex.org/I4405287703","https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089657867","display_name":"Hiroyasu Inada","orcid":"https://orcid.org/0000-0002-6230-4291","observed_orcids":["https://orcid.org/0000-0002-6230-4291"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hiroyasu Inada","raw_affiliation_strings":["Department of Pathology and Matrix Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Matrix Biology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083608125","display_name":"Toshimichi Yoshida","orcid":"https://orcid.org/0000-0001-8935-8217","observed_orcids":["https://orcid.org/0000-0001-8935-8217"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Toshimichi Yoshida","raw_affiliation_strings":["Department of Pathology and Matrix Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Matrix Biology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007438356","display_name":"Michiaki Hiroe","orcid":"https://orcid.org/0000-0003-1746-8585","observed_orcids":["https://orcid.org/0000-0003-1746-8585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michiaki Hiroe","raw_affiliation_strings":["Department of Nephrology and Cardiology, International Medical Center of Japan, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nephrology and Cardiology, International Medical Center of Japan, Tokyo, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040643509","display_name":"Kyoko Imanaka\u2010Yoshida","orcid":"https://orcid.org/0000-0002-8919-7342","observed_orcids":["https://orcid.org/0000-0002-8919-7342","https://orcid.org/0000-0002-9147-4169"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kyoko Imanaka-Yoshida","raw_affiliation_strings":["Department of Pathology and Matrix Biology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Matrix Biology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5040297237","https://openalex.org/A5040643509","https://openalex.org/A5083608125","https://openalex.org/A5089657867","https://openalex.org/A5102884477"],"corresponding_institution_ids":["https://openalex.org/I178574317"],"apc_list":null,"apc_paid":null,"fwci":3.1245,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.91820901,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"49","issue":"5","first_page":"261","last_page":"268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eplerenone","display_name":"eplerenone","score":0.9879999756813049},{"id":"https://openalex.org/keywords/myocardial-fibrosis","display_name":"myocardial fibrosis","score":0.9760000109672546},{"id":"https://openalex.org/keywords/tenascin-c","display_name":"tenascin-C","score":0.9750000238418579},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.8980000019073486},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8429999947547913},{"id":"https://openalex.org/keywords/aldosterone","display_name":"aldosterone","score":0.8939999938011169},{"id":"https://openalex.org/keywords/mineralocorticoid-receptor-antagonists","display_name":"mineralocorticoid receptor antagonists","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cardiac-fibroblasts","display_name":"cardiac fibroblasts","score":0.7870000004768372},{"id":"https://openalex.org/keywords/macrophage-accumulation","display_name":"macrophage accumulation","score":0.7760000228881836},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5809999704360962},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.8980000019073486},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pdgf-receptor-alpha","display_name":"PDGF receptor alpha","score":0.8240000009536743},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.7670000195503235},{"id":"https://openalex.org/keywords/hypertensive-heart-disease","display_name":"hypertensive heart disease","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.7572374939918518},{"id":"https://openalex.org/C117961784","wikidata":"https://www.wikidata.org/wiki/Q18027461","display_name":"Tenascin C","level":3,"score":0.6485919952392578},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6234214305877686},{"id":"https://openalex.org/C189135053","wikidata":"https://www.wikidata.org/wiki/Q3454531","display_name":"Mineralocorticoid receptor","level":3,"score":0.6193246841430664},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.619265079498291},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.6089738011360168},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5876842737197876},{"id":"https://openalex.org/C2780072264","wikidata":"https://www.wikidata.org/wiki/Q423804","display_name":"Eplerenone","level":4,"score":0.5424138307571411},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.5107090473175049},{"id":"https://openalex.org/C180361614","wikidata":"https://www.wikidata.org/wiki/Q7202242","display_name":"Platelet-derived growth factor receptor","level":4,"score":0.4542745053768158},{"id":"https://openalex.org/C3018763269","wikidata":"https://www.wikidata.org/wiki/Q5038318","display_name":"Myocardial fibrosis","level":3,"score":0.4339653253555298},{"id":"https://openalex.org/C2777420927","wikidata":"https://www.wikidata.org/wiki/Q5038318","display_name":"Cardiac fibrosis","level":3,"score":0.41876283288002014},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35908186435699463},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35039448738098145},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29584503173828125},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.2036241590976715},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.11698487401008606}],"mesh":[{"descriptor_ui":"D000077545","descriptor_name":"Eplerenone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000450","descriptor_name":"Aldosterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000804","descriptor_name":"Angiotensin II","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005355","descriptor_name":"Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014662","descriptor_name":"Vasoconstrictor Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017403","descriptor_name":"In Situ Hybridization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019063","descriptor_name":"Tenascin","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019063","descriptor_name":"Tenascin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/fjc.0b013e318033dfd4","doi":"https://doi.org/10.1097/fjc.0b013e318033dfd4","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0b013e318033dfd4","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:17513943","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17513943","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W134868223","https://openalex.org/W156930526","https://openalex.org/W234217880","https://openalex.org/W1518760783","https://openalex.org/W1541127944","https://openalex.org/W1554565279","https://openalex.org/W1963798186","https://openalex.org/W1967314793","https://openalex.org/W1968036401","https://openalex.org/W1977152294","https://openalex.org/W1982115885","https://openalex.org/W1985176515","https://openalex.org/W1986722306","https://openalex.org/W1993915795","https://openalex.org/W2006194591","https://openalex.org/W2030968333","https://openalex.org/W2034163879","https://openalex.org/W2036563539","https://openalex.org/W2044797498","https://openalex.org/W2061223357","https://openalex.org/W2062877889","https://openalex.org/W2065931840","https://openalex.org/W2084484653","https://openalex.org/W2101619182","https://openalex.org/W2105529472","https://openalex.org/W2108366713","https://openalex.org/W2111815907","https://openalex.org/W2115713362","https://openalex.org/W2116230802","https://openalex.org/W2125366323","https://openalex.org/W2126174661","https://openalex.org/W2127315646","https://openalex.org/W2150978153","https://openalex.org/W2152338271","https://openalex.org/W2153953287","https://openalex.org/W2153981371","https://openalex.org/W2170383755","https://openalex.org/W2308597156"],"related_works":["https://openalex.org/W2345468956","https://openalex.org/W2890880612","https://openalex.org/W2110920739","https://openalex.org/W1539984509","https://openalex.org/W3176551351","https://openalex.org/W2122254336","https://openalex.org/W2192174288","https://openalex.org/W2057428804","https://openalex.org/W2992993190","https://openalex.org/W2072219050"],"abstract_inverted_index":{"Tenascin-C":[0],"is":[1,7],"an":[2,119],"extracellular":[3],"matrix":[4],"glycoprotein":[5],"that":[6],"supposed":[8],"to":[9],"be":[10,181],"a":[11,31],"profibrotic":[12],"molecule":[13],"in":[14,25,45,70,114,171,183,196,200],"various":[15],"fibrogenic":[16],"processes.":[17],"To":[18],"elucidate":[19],"its":[20],"significance":[21],"for":[22],"myocardial":[23],"fibrosis":[24,188],"the":[26,115,137,172,184],"hypertensive":[27,175],"heart,":[28],"we":[29],"used":[30],"mouse":[32,176],"model":[33],"with":[34,118],"infusion":[35,77],"of":[36,65,80,86,130,153,165,186,205],"angiotensin":[37,75,126,157,173],"II":[38,58,76],"and":[39,48,63,74,90,105,111,132,160,189,215],"examined":[40],"results":[41,168],"by":[42,67,213],"histology,":[43],"immunohistochemistry,":[44],"situ":[46],"hybridization,":[47],"quantitative":[49],"real-time":[50],"reverse":[51],"transcriptase":[52],"polymerase":[53],"chain":[54],"reaction":[55],"(RT-PCR).":[56],"Angiotensin":[57],"treatment":[59],"elevated":[60],"blood":[61,138],"pressure":[62,139],"expression":[64,85,129,152,164],"tenascin-C":[66,151,179,203],"interstitial":[68],"fibroblasts":[69,206],"perivascular":[71],"fibrotic":[72],"lesions,":[73],"caused":[78],"accumulation":[79],"macrophages.":[81],"It":[82],"also":[83],"upregulated":[84,163],"collagen":[87],"Ialpha2;":[88],"IIIalpha1;":[89],"proinflammatory/profibrotic":[91],"mediators":[92],"including":[93],"transforming":[94],"growth":[95,100],"factor":[96,101],"beta":[97],"(TGFbeta),":[98],"platelet-derived":[99],"alpha":[102],"(PDGF-A),":[103],"PDGF-B,":[104],"PDGF-receptor":[106,112],"alpha,":[107],"but":[108],"not":[109],"IL-1beta":[110],"beta,":[113],"myocardium.":[116],"Treatment":[117],"aldosterone":[120,146,191],"receptor":[121],"antagonist,":[122],"eplerenone,":[123],"significantly":[124,162],"attenuated":[125],"II-induced":[127,174],"fibrosis,":[128],"tenascin-C,":[131],"inflammatory":[133,194],"changes":[134],"without":[135],"affecting":[136],"level.":[140],"In":[141],"vitro,":[142],"neither":[143],"eplerenone":[144],"nor":[145],"exerted":[147],"any":[148],"influence":[149],"on":[150],"cardiac":[154,187],"fibroblasts,":[155],"whereas":[156],"II,":[158],"TGF-beta1,":[159],"PDGF":[161],"tenascin-C.":[166],"These":[167],"suggest":[169],"that,":[170],"heart:":[177],"(1)":[178],"may":[180,192],"involved":[182],"progression":[185],"(2)":[190],"elicit":[193],"reactions":[195],"myocardium,":[197],"which":[198],"might,":[199],"turn,":[201],"induce":[202],"synthesis":[204],"through":[207],"at":[208],"least":[209],"2":[210],"pathways":[211],"mediated":[212],"TGF-beta":[214],"PDGF-A-B/PDGF-receptor":[216],"alpha.":[217]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}